PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.99%
Revenue growth 1.25-1.5x 3141.T's 6.16%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
7.85%
Gross profit growth similar to 3141.T's 7.40%. Walter Schloss would assume both firms track common industry trends.
33.42%
EBIT growth 1.25-1.5x 3141.T's 29.69%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
36.79%
Operating income growth at 75-90% of 3141.T's 42.34%. Bill Ackman would demand a plan to enhance operating leverage.
30.54%
Net income growth comparable to 3141.T's 32.80%. Walter Schloss might see both following similar market or cost trajectories.
30.59%
EPS growth similar to 3141.T's 32.88%. Walter Schloss would assume both have parallel share structures and profit trends.
30.59%
Similar diluted EPS growth to 3141.T's 32.88%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.95%
10Y revenue/share CAGR above 1.5x 3141.T's 8.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
32.95%
5Y revenue/share CAGR above 1.5x 3141.T's 8.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
32.95%
3Y revenue/share CAGR above 1.5x 3141.T's 8.31%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.73%
Net income/share CAGR at 50-75% of 3141.T's 125.75%. Martin Whitman might question if the firm’s product or cost base lags behind.
65.73%
5Y net income/share CAGR at 50-75% of 3141.T's 125.75%. Martin Whitman might see a shortfall in operational efficiency or brand power.
65.73%
3Y net income/share CAGR 50-75% of 3141.T's 125.75%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.30%
Inventory shrinking or stable vs. 3141.T's 7.44%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.44%
Asset growth at 50-75% of 3141.T's 4.73%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.23%
1.25-1.5x 3141.T's 4.36%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-36.39%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.